Global Non-Ionizing Breast Imaging Market, By Type (Breast Ultrasound, Breast MRI, Automated Whole-breast Ultrasound (AWBU), Breast thermography, Electric Impedance Tomography, Optical Imaging), End User (Hospital, Diagnostic Imaging Centre, Others) – Industry Trends and Forecast to 2029.
Global Non-Ionizing Breast Imaging Market Analysis and Size
According to the World Health Organization (WHO), breast cancer is the second most common cancer among women, and more than 200,000 new cases of cancer are diagnosed every year worldwide. The rising incidence of breast cancer has further increased awareness of breast cancer early detection across the globe. As a result, supportive government initiatives aid in spreading awareness about cancer risk factors, preventive measures and early detection. Consequently, these growth determinants will fuel the expansion of the market over the forecasted period.
- The non-ionizing breast imaging market was valued at USD 4.02 billion in 2021 and is expected to reach USD 7.77 billion by 2029, registering a CAGR of 8.60% in 2022-2029. The "breast ultrasound" accounts for the largest type segment in the non-ionizing breast imaging market within the forecasted period owing to the lower risk of exposure to radiation and the various benefits such as the ability to detect lesions and the ability to differentiate between a cyst and a solid mass and the detection of blood flow through vessels. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Non-Ionizing Breast Imaging Market Definition
Breast imaging is a diagnostic radiology subspecialty that involves imaging breasts for diagnostic or screening purposes. Breast imaging technologies are used to study the tissues of women's breasts in order to diagnose breast cancer and other breast-related diseases. Some of the most popular breast imaging examinations include mammograms, breast magnetic resonance imaging (MRI), and ultrasound.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Breast Ultrasound, Breast MRI, Automated Whole-breast Ultrasound (AWBU), Breast thermography, Electric Impedance Tomography, Optical Imaging), End User (Hospital, Diagnostic Imaging Centre, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Hologic, Inc. (U.S.), General Electric (U.S.), Siemens (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (U.S.), Allengers (India), Dilon Medical Technologies, Inc. (U.S.), Siemens (Germany), Planmed Oy. (Finland), Delphinus Medical Technologies, Inc. (U.S.), Micrima Limited (UK), CMR Naviscan Corporation (U.S.), SuperSonic Imagine (France) and Carestream Health (U.S.)
|
|
Market Opportunities
|
|
Non-Ionizing Breast Imaging Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Requirement for Diagnosis
The rising prevalence of breast cancer is the most significant factor driving the growth for this market as it further requires diagnosis and screening. The increasing population of women who are more susceptible to breast cancer is also projected to bolster the market's growth.
Furthermore, the expanding healthcare sector along with the rise in demand for early diagnosis are also expected to fuel market growth. Moreover, the increasing number of screening programs, as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis, also cushions the market's growth within the forecasted period.
Opportunities
- Improving Reimbursement, Funding and Investments
Moreover, the improving reimbursement scenario and increase in funding from private and government organizations for the development of healthcare infrastructure are estimated to generate lucrative opportunities for the market. The growing government and private investments to meet the increasing demand for breast cancer screening will further offer numerous growth opportunities for the market.
Restraints/Challenges Global Non-Ionizing Breast Imaging Market
- High Costs
On the other hand, the high cost required for detecting breast cancer is expected to obstruct market growth.
- Effects of Radiation
The adverse effects from exposure to radiation leads to the lesser population turn up for the procedure. This factor is estimated to impede the overall growth of the market.
- Strict Regulations
Also, the stringent regulatory approval procedures are projected to challenge the non-ionizing breast imaging market in the forecast period of 2022-2029.
This non-ionizing breast imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-ionizing breast imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Non-Ionizing Breast Imaging Market
The emergence of COVID-19 pandemic put a strain on healthcare systems all around the world. The non-ionizing breast imaging market was largely impacted by the outbreak of COVID-19.
During the pandemic, the imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales further limits the industry's expansion. The implementation of lockdown resulted in a decrease in the number of patient visits for other diseases such as cancer and diabetes. According to the Eurasian Journal of Medical Investigation (EJMI), between April and July 2020, there was a 41.7 percent -64.4 percent reduction in the number of breast imaging modalities. The mammography technology showed the most significant decline. The mammography technology showed the most significant decline.
Recent Developments
- In April 2021, Seno Medical's Imagio P200003 Breast Imaging System has been authorized by the US Food and Drug Administration (FDA). The Imagio Breast Imaging System images breast tissues using both optoacoustic (OA) and ultrasound (US) technology to assist clinicians in examining breast abnormalities.
- In April 2021, Dilon Technologies Inc., the owner of the Navigator Gamma Probes and a world-class global leader in breast cancer therapy and detection, has acquired all of Dune Medical's assets, including Dune Medical's "MarginProbe essentially."
Global Non-Ionizing Breast Imaging Market Scope
The non-ionizing breast imaging market is segmented on the basis of type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Breast Ultrasound
- Breast MRI
- Automated Whole-breast Ultrasound (AWBU)
- Breast thermography
- Electric Impedance Tomography
- Optical Imaging
On the basis of type, the non-ionizing breast imaging market is segmented into breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography and optical imaging. The breast ultrasound segment is projected to account for the largest share owing to the lower risk of exposure to radiation and the various benefits such as the ability to detect lesions and the ability to differentiate between a cyst and a solid mass and the detection of blood flow through vessels.
End User
- Hospital
- Diagnostic Imaging Centre
- Others
On the basis of end user, the non-ionizing breast imaging market is bifurcated into hospital, diagnostic imaging centre and others.
Non-Ionizing Breast Imaging Market Regional Analysis/Insights
The non-ionizing breast imaging market is analyzed and market size insights and trends are provided by country, type and end user as referenced above.
The countries covered in the non-ionizing breast imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the non-ionizing breast imaging market because of the substantial research and development expenditure, well-established healthcare infrastructures, widespread acceptance of advanced medical technologies and superior reimbursement facilities within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rising government and non-government initiatives to prevent breast cancer coupled with the constant development in the healthcare infrastructures within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The non-ionizing breast imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for non-ionizing breast imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the non-ionizing breast imaging market. The data is available for historic period 2010-2020.
Competitive Landscape and Non-Ionizing Breast Imaging Market Share Analysis
The non-ionizing breast imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to non-ionizing breast imaging market.
Some of the major players operating in the non-ionizing breast imaging market are
- Hologic, Inc. (U.S.)
- General Electric (U.S.)
- Siemens (Germany)
- Koninklijke Philips N.V. (Netherlands)
- Fujifilm Holdings Corporation (Japan)
- Canon Inc. (Japan)
- Aurora Healthcare US Corp. (U.S.)
- Allengers (India)
- Dilon Medical Technologies, Inc. (U.S.)
- Siemens (Germany)
- Planmed Oy. (Finland)
- Delphinus Medical Technologies, Inc. (U.S.)
- Micrima Limited (U.K)
- CMR Naviscan Corporation (U.S.), SuperSonic Imagine (France)
- Carestream Health (U.S.)
Research Methodology : Global Non-Ionizing Breast Imaging Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-non-ionizing-breast-imaging-market
SKU-